In the News

Recent Coverage of HMS in the News
December 29, 2012

For years, doctors, scientists, and ethicists have debated whether people will benefit from decoding their DNA, the three billion letters of the genome that spell out traits and predisposition to disease. Now, that complicated conversation is moving to a new venue: the newborn nursery. Alan Beggs, the Sir Edwin and Lady Manton Professor of Pediatrics at Boston Children’s Hospital and Robert Green, HMS lecturer on medicine at Brigham and Women’s Hospital, designed a trial to measure benefits and risks of newborn sequencing.

December 27, 2012

Dozens of cancer drugs have been in short supply in recent years as manufacturers closed factories, stopped making products, or halted operations because of quality control problems. Researchers have struggled to quantify the effect shortages have had on patient care, and a new article advances that effort. Amy Billett, HMS associate professor of pediatrics at Dana-Farber Cancer Institute, was one of the authors of the study.

December 27, 2012

Isaac S. Kohane, the Lawrence J. Henderson Professor of Pediatrics at Boston Children’s Hospital and director of the Countway Library of Medicine at HMS; Jeffrey M. Drazen, the Parker B. Francis Distinguished Professor of Medicine at Brigham and Women's Hospital and editor-in-chief of The New England Journal of Medicine; and Edward W. Campion, HMS assistant professor of medicine at Massachusetts General Hospital, published an editorial looking forward at what medicine may look like in the next 100 years.

December 24, 2012

When faced with a thorny medical problem, Jeffrey Karp, HMS associate professor of medicine at Brigham and Women's Hospital, and his students sometimes head to Franklin Park Zoo or the New England Aquarium because animal life is a big source of inspiration for Karp and his colleagues at the center on regenerative therapeutics he runs. Robert S. Langer, HMS senior lecturer on surgery and Mehmet Toner, the Helen Andrus Benedict Professor of Surgery at Massachusetts General Hospital, are also quoted.

December 21, 2012

The “personalized” approach to treating cancer, which subdivides the classic types according to distortions in their genes, has been growing at a rapid pace. Raju Kucherlapati, the Paul C. Cabot Professor of Genetics at HMS, is quoted.

December 20, 2012

Biogen Idec Inc. said yesterday that it has formed a consortium with several academic research centers that looks to identify new approaches to treating amyotrophic lateral sclerosis, or ALS, which is also known as Lou Gehrig’s disease. Spyros Artavanis-Tsakonas, HMS professor of cell biology, is also the company’s senior vice president and chief scientific officer.

December 20, 2012

An international team, including researchers from HMS, found the effectiveness of a range of common sleeping tablets were of “questionable clinical importance.”

December 18, 2012

Richard Keller pleaded not guilty Tuesday to possessing and receiving child pornography, including some that authorities said he had shipped to the student health center at the elite boarding school where he worked. Keller has worked at Boston Children’s Hospital and taught at Harvard Medical School and has been placed on administrative leave.


Submit Photo Requests to HMS
To request photos from the HMS Office of Communications and External Relations, click here.


Tell us about your awards
Share news of your achievements with the larger HMS community,  click here.


Book Reviews
If you are a faculty member who has published a book recently, click here.